HUMANIGEN INC (HGEN) Stock Analyst Earnings Estimates
NASDAQ:HGEN - Nasdaq - US4448632038 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 310K | 3.595M 1,059.68% | 2.514M -30.07% | 204K -91.89% | -100.00% | 44.472M | 87.516M 96.79% | 97.41M 11.31% | 105.77M 8.58% | 114.75M 8.49% | 124.44M 8.44% | |
| EBITDA YoY % growth | N/A -985.41% | N/A -164.94% | N/A 69.96% | -30.6M 60.37% | -26.47M 13.50% | -17.639M 33.36% | -111.486M -532.05% | -121.992M -9.42% | -109.14M 10.54% | N/A | N/A | |
| EBIT YoY % growth | -88.2M -886.58% | -232.772M -163.91% | -68.304M 70.66% | -47.43M 30.56% | -25.679M 45.86% | -9.125M 64.46% | 23.256M 354.85% | 30.906M 32.89% | 37.128M 20.13% | 43.962M 18.41% | 51.408M 16.94% | |
| Operating Margin | -28,451.61% | -6,474.88% | -2,716.95% | -23,250.00% | N/A | -20.52% | 26.57% | 31.73% | 35.10% | 38.31% | 41.31% | |
| EPS YoY % growth | N/A | -4.10 -123.49% | -0.93 77.32% | -0.15 83.55% | -0.09 40.00% | 0.08 188.89% | 0.06 -25.00% | 0.07 16.67% | 0.09 28.57% | 0.11 22.22% | 0.12 9.09% |
All data in USD
| Q2 / 23 | Q3 / 23 | Q4 / 23 | Q1 / 24 | Q2 / 24 | Q3 / 24 | Q4 / 24 | |
|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.04 90.51% | -0.04 82.26% | -0.03 -161.20% | -0.02 49.00% | -0.02 50.00% | -0.02 50.00% | -0.02 33.33% |
| Revenue Q2Q % growth | -100.00% | -100.00% | -100.00% | -100.00% | |||
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -5.202M 82.28% | -5.406M 76.21% | -5.712M -232.93% | -5.1M -20.43% | -4.998M 3.92% | -4.896M 9.43% | -4.692M 17.86% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2023 Q2Q % growth | -0.04 87.50% | -0.06 | 0.02 | 34.64% |
| Q4 2022 Q2Q % growth | 0.05 109.43% | -0.06 | 0.11 | 179.06% |
| Q3 2022 Q2Q % growth | -0.23 79.46% | -0.18 | -0.05 | -24.93% |
| Q2 2022 Q2Q % growth | -0.43 64.17% | -0.30 | -0.13 | -42.54% |
| Q1 2022 Q2Q % growth | -0.32 74.40% | -0.47 | 0.15 | 32.19% |
| Q4 2021 Q2Q % growth | -0.53 15.87% | -0.66 | 0.13 | 19.57% |
| Q3 2021 Q2Q % growth | -1.12 -57.75% | -1.00 | -0.12 | -11.59% |
| Q2 2021 Q2Q % growth | -1.20 | -0.88 | -0.32 | -36.56% |
| Q1 2021 Q2Q % growth | -1.25 | -0.65 | -0.60 | -91.48% |
| Q4 2020 Q2Q % growth | -0.63 | -0.69 | 0.06 | 8.09% |
| Q3 2020 Q2Q % growth | -0.71 | -0.58 | -0.13 | -22.84% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2023 Q2Q % growth | 221K -78.67% | 221K | % | |
| Q4 2022 Q2Q % growth | 221K -78.69% | 102K | 119K | 116.67% |
| Q3 2022 Q2Q % growth | 221K -78.67% | 530.4K | -309.4K | -58.33% |
| Q2 2022 Q2Q % growth | 1.036M | 530.4K | 505.6K | 95.32% |
| Q1 2022 Q2Q % growth | 1.036M 111.43% | 265.2K | 770.8K | 290.65% |
| Q4 2021 Q2Q % growth | 1.037M 234.52% | 428.4K | 608.6K | 142.06% |
| Q3 2021 Q2Q % growth | 1.036M | 68.003K | 967.997K | 1,423.45% |
| Q2 2021 Q2Q % growth | 1.036M | 975.12K | 60.88K | 6.24% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 33.33% | 41.75% | 41.75% |
| Revenue | N/A | N/A | N/A | N/A |